Osteoporosis: diagnosis, prevention, and treatment of established disease.
Dunlop
M B
MB
Rosalind Russell Arthritis Research Laboratory, San Francisco General Hospital, CA, USA.
Lane
N E
NE
D000367:Age Factors; D000368:Aged; D019386:Alendronate / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000627:therapeutic use; D019587:Dietary Supplements; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000172:deficiency; D012968:Etidronic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D015444:Exercise; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy / Q000517:prevention & control; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D000068296:Risedronic Acid; D018570:Risk Assessment; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D002136:Calcium, Dietary; D004967:Estrogens; D020845:Selective Estrogen Receptor Modulators; D014807:Vitamin D; D020849:Raloxifene Hydrochloride; D002116:Calcitonin; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate